← Evidence map

ArticleCureus2025

Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival Outcomes.

Pravesh Dhiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival Outcomes. | OpenQuestion